Survey about Venous Thrombo-Embolism (VTE) Prophylaxis. Nurses

Similar documents
Organizational Initiative

Prevention and Treatment of Venous Thromboembolism (VTE) Policy

Low Molecular Weight Heparins

Preventing hospital-acquired blood clots

Raising Awareness: Venous Thromboembolism Prevention and Reduction in the Orthopedic Patient Population

Andrea Croft RGN Lead Advanced Nurse Practitioner Anticoagulation. Welsh Nurse Director Thrombosis UK

Are you at risk of blood clots?

Statement 2: Patients/carers are offered verbal and written information on VTE prevention as part of the admission process.

After reading this learning module, the nurse should be able to:

University College London Hospitals (UCLH) Preventing venous thromboembolism (VTE)

Venous Thromboembolism Prophylaxis. Robert A. Thompson, MD, MBA Karen Bales, RN, BSN

Policy for Venous Thromboembolism Prevention and Treatment

POLICY FOR the Assessment, Prevention and Treatment of Venous Thrombo-Embolism. Policy Reference: Version: 1 Status: Approved

Inpatient Quality Reporting Program

National Blood Clot Alliance

Multidisciplinary Performance Improvement. Improving patient outcomes by decreasing VTE through interprofessional collaboration

Person/persons conducting this assessment with Contact Details Marilyn Rees Lead VTE Nurse ext 48729

Venous Thromboembolism (VTE)

CarePartners Nursing Care Plan Anticoagulant Therapy

DANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017]

THE PREVENTION AND MANAGEMENT OF VTE IN CARE HOMES:

Required Organizational Practices Resources for 2016

SCIP. Surgical Care Improvement Project. Making Surgeries Safer. By: Roshini Mathew, RN

Fast Facts 2018 Clinical Integration Performance Measures

OHA HEN 2.0 Partnership for Patients Letter of Commitment

SCORING METHODOLOGY APRIL 2014

Developing Practice for Thrombosis Prevention in Medical Patients at Queens Medical Centre Campus, Nottingham University Hospitals

Welcome and Instructions

NHS Safety Thermometer

Blood clot prevention. A guide for patients and carers

Fifth Annual Audit of Acute NHS Trusts VTE Policies

Preventing Blood Clots in Hospitals

Nursing Grand Rounds: VTE Safety Toolkit

PATIENT ASSESSMENT POLICY Page 1 of 7

Guidance notes to accompany VTE risk assessment data collection

Better to Best Quality Excellence Achievement Awards. Recognizing Illinois Hospitals Leading in Quality and Innovation COMPENDIUM

PSI 12 - Perioperative Pulmonary Embolism or Deep Vein Thrombosis Rate Opportunity

27 th May 2011 Anticoagulation in Practice. Dr Jennie Wimperis Consultant Haematologist

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

NoCVA SSI/VTE Safe Surgery Collaborative

Deep Vein Thrombosis (DVT) - Blood Clots

National Hemophilia Program Coordinating Center (NHPCC)

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

HEMOPHILIA & THROMBOSIS

Venous Thromboembolism (VTE) Audit Day

Please find below our questionnaire completed with the information we hold.

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION

The Newcastle upon Tyne Hospitals NHS Foundation Trust Venous. Thromboembolism (VTE) Assessment and Management

VTE Prevention. Workflow Processes

VAE PROJECT MASTER ACTION PLAN. Note: Please be aware that these areas overlap to reduce duplication and optimize the synergies

Achieving Positive Clinical Outcomes, Cost Savings, and Regulatory Compliance using Clinical Decision Support Alerts in the Electronic Health Record

Venous Thromboprophylaxis (VTE) Policy

Open and Honest Care in your Local Hospital

Instructions for Integrated Care Pathway use

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved

Ref: FOI/CAD/ID December Freedom of Information Act 2000

Case Presentation. Cindy Felty MSN, RN, CNP, FCCWS Assistant Professor of Medicine Mayo Clinic March 27, 2008

Commissioning for quality and innovation (CQUIN): 2013/14 guidance. Draft December 2012

Nursing care plan for anticoagulation therapy

From the Feds: Research, Programs, and Products

National Provider Call: Hospital Value-Based Purchasing

Best Practice Guidelines - BPG 7 VTE (Venous Thrombo Embolism)

ARTICLE. The community pharmacybased anticoagulation management service achieves a consistently high standard of anticoagulant care

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION

Venous Thromboembolism Policy

Northern Health - Acute Services. Evidence Based Practice Venous Thromboembolism Prevention

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

Clinical Policies Group notified to Quality and Safety Operational Group Approval Date 31/05/2017 Initial Equality Impact Screening

Hospital Inpatient Quality Reporting (IQR) Program Measures (Calendar Year 2012 Discharges - Revised)

Preventing Avoidable Venous Thromboembolism: Every Patient, Every Time

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION

Axillary Node Dissection

SAVTE is A Subsidiary of The PROFILE.

Iowa Healthcare Collaborative - HEN 2.0 Measures

Medical Intensive Care Unit Rotation EUHM

Open and Honest Care in your Local Hospital

HIMSS 2013 Davies Enterprise Award Application Texas Health Resources. Core Case Study Clinical Value

National Hospital Inpatient Quality Reporting Measures Specifications Manual

Accreditation Program: Long Term Care

Inpatient & Outpatient Venous Thromboembolism: A Multifactorial Approach to Increase Mechanical and Pharmacological Prophylaxis Compliance

Getting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 5: VTE Prophylaxis Improvement Guide

Scoring Methodology FALL 2016

BTS Guidelines for the initial outpatient management of pulmonary embolism (PE)

Hospital data to improve the quality of care and patient safety in oncology

Thromboprophylaxis in Adult General Medical Patients - Guidelines for Management

Use of Information Technology in Physician Practices

ASCs and Meaningful Use. Patrick Doyle, Vice President Sales Jessica McBrayer, RN, Business Analyst Ron Pelletier, Vice President Market Strategy

Beyond Warfarin Clinic : Pharmacistmanaged. Anticoagulation Care Services

The Iowa Healthcare Collaborative - HEN Measure Descriptions

South East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions

Patient-Centered Connected Care 2015 Recognition Program Overview. All materials 2016, National Committee for Quality Assurance

TQIP Monthly Registry Staff Web Conference. July 31, 2014

Venous Thromboembolism (VTE) Prevention and Management Policy and Procedures

SUTTER MEDICAL CENTER, SACRAMENTO EDUCATION TEAM Physician Continuing Medical Education Application And Process

Module 1 Program Description

The HITECH EHR "Meaningful Use" Requirements for Hospitals and Eligible Professionals

Seniors Health Research Priority Setting Partnership Survey. Identifying what is important to seniors health in Alberta

Medication Safety Dashboard

Patient Safety Initiatives

Transcription:

Survey about Venous Thrombo-Embolism (VTE) Prophylaxis Nurses

Dear staff member, This is a short survey about venous thromboembolism (VTE) at your hospital organization. Venous Thromboembolism (VTE) is comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE). It will take about 5 minutes of your time to fill out the survey. Completion of the survey is voluntary. We are collecting information about your job and your perceptions about VTE. You may leave blank any questions you do not want to answer. Your responses are strictly confidential and will be closely guarded. Research staff will be the only people to see your answers. Your name and other identifying information will not be associated with your survey answers. All results of this study will be reported in the aggregate so that no one person can be identified. No answers of individuals will ever be released. It is our hope that through the information we obtain from this study, we can better understand how VTE prophylaxis has an impact on patient care. Thank you for your consideration. Instructions To answer the questions, check the appropriate box on the scale. For example: 1. How an issue is the prevention of VTE in hospitalized patients? 1. Not very 2. 3. 4. Moderately 5. 6. 7. 1 2 3 5 6 Some questions will require answers similar to the scale above, while other questions will require different responses. Please try to be as accurate as possible. 1

Section A. About your job 1. Please, check your current job position: 1 Registered Nurse (RN) 2 Licensed Practical Nurse (LPN) 3 Other. 2. On which unit do you work? 1 Trauma and Life Support Center (TLC) 2 D4/4 3 D4/6 4 D6/5 5 F6/5 6 Other:. 3. What is your gender? 1 Male 2 Female 4. How old are you? 1 24 years or younger 2 25-29 3 30-34 4 35-39 5 40-44 6 45-49 7 50-54 8 55-59 9 60 years or older 5. How long have you worked at your current healthcare organization? years months Venous Thromboembolism (VTE) is comprised of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) 2

Section B. Perceptions about Venous Thromboembolism (VTE) prophylaxis The following questions are about your perceptions regarding VTE 1. How an issue is the prevention of VTE in hospitalized patients? Not very 1 2 3 Moderately 2. To your knowledge, how are currently used anticoagulant strategies for the prevention of VTE in hospitalized patients? Not very at all 1 2 3 Moderately 3. How safe are currently used anticoagulant strategies for the prevention of VTE in hospitalized patients? Not very safe at all 1 1 3 Neither unsafe, nor safe safe 4. How under- or over-utilized are current anticoagulant strategies? Underutilized Appropriately utilized Overutilized 1 2 3 Section C. Possible s to VTE prophylaxis The following questions are about possible system s to VTE Please rate the following system s to VTE prophylaxis in your hospital on a scale from 1 (not a ) to 7 (very large ). 1. Lack of time to consider VTE prophylaxis in every patient. 2. Lack of clear indications for VTE prophylaxis (i.e., who should get prophylaxis). 3. Lack of clear contra-indications for VTE prophylaxis (i.e., who should not get prophylaxis). 4. Lack of awareness about ness of VTE 5. Lack of physician agreement with current VTE prophylaxis guidelines. 6. Patient discomfort from subcutaneous injections of anticoagulants. 7. Clinician concerns about increased bleeding risk from anticoagulant administration. 8. Use of VTE prophylaxis (e.g. Lovenox) increases the risk of bleeding when ambulating the patient Not a small Small Moderate Substantial Large large 3

Section D. Effectiveness of interventions to increase VTE prophylaxis The next questions are about the possible ness of (potential) interventions to address VTE Please read the different options carefully because there are minor differences between some of the different options. Not all of the options below are technologically feasible with the current state of the art. in Neither in nor 1. Yearly multidisciplinary educational meetings for healthcare professionals to review VTE prophylaxis in hospitalized patients. 2. Posters on the units to remind healthcare professionals about VTE 3. Laminated pocket cards to remind healthcare professionals about VTE 4. Order sets to remind healthcare professionals about VTE 5. A hard stop in the admission order set to make sure that VTE prophylaxis is assessed. 6. A risk assessment tool in the admission order set to create a VTE prophylaxis order based on patient s low, medium or high risk for VTE. 7. Semi-automated computer decision support that automatically calculates the patient s VTE risk 8. Computerized reminders (alerts) to prompt physicians to consider VTE prophylaxis upon opening a patient s medical record. 9. Physician progress note template that prompts for VTE 10. Computerized alert to inform physicians that VTE prophylaxis has been interrupted and may need to be resumed. 11. Computerized alert to inform physicians that VTE contraindications have changed. 12. Nurse reminders to the physician about VTE 13. Pharmacist reminders to the physician about VTE 14. Physical therapist reminders to the physician about VTE 15. Periodic audit and feedback on compliance with VTE prevention practice guidelines. 16. Use of a local opinion leader to promote evidence-based use of VTE prophylaxis guidelines. 4

Section E. Guestimates of VTE prophylaxis In the following section you are asked to guestimate how often VTE prophylaxis is ordered and interrupted (for example because of a procedure) and afterwards resumed. We do realize that it is not easy to guestimate those percentages. However, several studies have shown that group guestimates (the average of all guestimates) are fairly accurate. 1. Overall, what percentage of patients is appropriately put on VTE prophylaxis at admission? 0-10% 11-20% 21-30% 31-40% 41-50% 51-60% 61-70% 71-80% 81-90% 91-100% 8 9 10 2. For what percentage of patients is VTE prophylaxis interrupted or stopped during a patient stay, e.g., because of a procedure? 0-10% 11-20% 21-30% 31-40% 41-50% 51-60% 61-70% 71-80% 81-90% 91-100% 8 9 10 3. When VTE prophylaxis has been interrupted (e.g., because the patient needs to undergo a procedure), for what percentage of patients is VTE prophylaxis resumed after the interruption? 0-10% 11-20% 21-30% 31-40% 41-50% 51-60% 61-70% 71-80% 81-90% 91-100% 8 9 10 Section F. Who is best equipped to take care of VTE prophylaxis during the patient stay The final three questions are about different roles and responsibilities for VTE prophylaxis (select one role for each activity). Which clinician group is best able (select one) 1. to provide daily assessment of patient need for VTE prophylaxis? 2. to ensure VTE prophylaxis is ordered? 3... to ensure adherence once VTE prophylaxis is prescribed? Attending physician Fellow Physician assistant or Nurse Practitioner Resident Consultant physician Nurse Pharmacist Physical therapist 8 8 8 Thank you for your participation! 5